Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Manuela Monti
Observed names:
M. Monti,
Manuela MONTI,
Monti, Manuela
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institutions:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Ospedale Cervesi di Cattolica,
Istituto Ortopedico Rizzoli,
Istituto Oncologico Romagnolo,
Fondazione IRCCS Istituto Nazionale dei Tumori
ORCID:
0000-0002-3587-1768
Observed ORCID:
0000-0002-3587-1768
OpenAlex ID:
A5000135524
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE
2016
·
Maddalena Sansovini
, Stefano Severi
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
126
177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study
2014
·
Giovanni Paganelli
, Maddalena Sansovini
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
126
Treatment with the Radiolabelled Somatostatin Analog 177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
2013
·
Maddalena Sansovini
, Stefano Severi
, et al.
·
Neuroendocrinology
·
122
Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET
2015
·
Annarita Ianniello
, Maddalena Sansovini
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
111
PDF
Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC
2015
·
Stefano Severi
, Maddalena Sansovini
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
74
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors
2021
·
Silvia Nicolini
, Lisa Bodei
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
68
Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case report
2019
·
Salvatore Bellia
, Giacomo Feliciani
, et al.
·
Journal of Contemporary Brachytherapy
·
62
PDF
Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients
2020
·
Giovanni Paganelli
, Anna Sarnelli
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
59
Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol
2019
·
Anna Sarnelli
, Maria Luisa Belli
, et al.
·
Molecules
·
57
PDF
Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial
2021
·
Ugo De Giorgi
, Maddalena Sansovini
, et al.
·
British Journal of Cancer
·
37
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study
2020
·
Giovanni Paganelli
, Maddalena Sansovini
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
35
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET
2024
·
A. Gennari
, E. Brain
, et al.
·
Annals of Oncology
·
34
PDF
Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT
2021
·
Gianluca Bottoni
, Arnoldo Piccardo
, et al.
·
European Journal of Radiology
·
34
PDF
Accelerated hypofractionated radiotherapy plus chemotherapy for inoperable locally advanced non-small-cell lung cancer: final results of a prospective phase-II trial with a long-term follow-up
2019
·
Elisabetta Parisi
, Giovenzio Genestreti
, et al.
·
Radiation Oncology
·
28
PDF
Production and Quality Control of [177Lu]Lu-PSMA-I&T: Development of an Investigational Medicinal Product Dossier for Clinical Trials
2022
·
Valentina Di Iorio
, Stefano Boschi
, et al.
·
Molecules
·
27
PDF
Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study
2023
·
Gianluca Bottoni
, Francesco Fiz
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
21
Coordinatori di ricerca clinica: una risorsa indispensabile
2019
·
Celeste Cagnazzo
, Sara Testoni
, et al.
·
Recenti Progressi in Medicina
·
21
PDF
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer
2017
·
Andrea Rocca
, Lorenzo Cecconetto
, et al.
·
Cancer Chemotherapy and Pharmacology
·
21
PDF
Hydroxychloroquine as Prophylaxis for COVID-19: A Review
2020
·
Manuela Monti
, Bernadette Vertogen
, et al.
·
Frontiers in Pharmacology
·
18
PDF
68Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy
2020
·
Paola Caroli
, Sarah Pia Colangione
, et al.
·
Biomedicines
·
18
PDF
Clinical research and burnout syndrome in Italy – only a physicians’ affair?
2021
·
Celeste Cagnazzo
, Roberto Filippi
, et al.
·
Trials
·
17
PDF
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature
2014
·
Toni Ibrahim
, Alberto Bongiovanni
, et al.
·
OncoTargets and Therapy
·
17
PDF
Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
2021
·
Donatella Arpa
, Elisabetta Parisi
, et al.
·
Frontiers in Oncology
·
16
PDF
Endobronchial/Endoesophageal Ultrasound (EBUS/EUS) Guided Fine Needle Aspiration (FNA) and 18F-FDG PET/CT Scanning in Restaging of Locally Advanced Non-small Cell Lung Cancer (NSCLC) Treated with Chemo-radiotherapy: A Mono-institutional Pilot Experience
2014
·
Giovenzio Genestreti
, Marco Angelo Burgio
, et al.
·
Technology in Cancer Research & Treatment
·
16
How Many Cancer Clinical Trials Can a Clinical Research Coordinator Manage? The Clinical Research Coordinator Workload Assessment Tool
2020
·
Francesca Fabbri
, Giorgia Gentili
, et al.
·
JCO Oncology Practice
·
15
Show more works
View as search
Works count:
73
Citation count:
1,312
H-index:
18
I10-index:
28
Year
Topic
Type